2021
DOI: 10.1161/jaha.120.019413
|View full text |Cite
|
Sign up to set email alerts
|

Arterial Platelet Adhesion in Atherosclerosis‐Prone Arteries of Obese, Insulin‐Resistant Nonhuman Primates

Abstract: Background Platelet–endothelial interactions are thought to contribute to early atherogenesis. These interactions are potentiated by oxidative stress. We used in vivo molecular imaging to test the hypothesis that platelet–endothelial interactions occur at early stages of plaque development in obese, insulin‐resistant nonhuman primates, and are suppressed by NADPH‐oxidase‐2 inhibition. Methods and Results Six adult rhesus macaques fed a We… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 39 publications
0
10
0
Order By: Relevance
“…IR can interfere with insulin signaling, enhance chronic systemic inflammation, reduce insulin sensitivity, and increase foam cell formation, thereby accelerating the formation of atherosclerosis and advanced plaques [ 45 49 ]. IR can also affect the metabolism of insulin-like growth factor-1 (IGF-1), insulin-like growth factor-2 (IGF-2) [ 50 ], cyclic guanosine monophosphate (cGMP), and nitric oxide(NO) [ 51 ], thus playing key roles in platelet adhesion, activation, and aggregation [ 52 54 ]. These pathways lead to vascular occlusion and in the pathogenesis of IS [ 54 56 ].…”
Section: Discussionmentioning
confidence: 99%
“…IR can interfere with insulin signaling, enhance chronic systemic inflammation, reduce insulin sensitivity, and increase foam cell formation, thereby accelerating the formation of atherosclerosis and advanced plaques [ 45 49 ]. IR can also affect the metabolism of insulin-like growth factor-1 (IGF-1), insulin-like growth factor-2 (IGF-2) [ 50 ], cyclic guanosine monophosphate (cGMP), and nitric oxide(NO) [ 51 ], thus playing key roles in platelet adhesion, activation, and aggregation [ 52 54 ]. These pathways lead to vascular occlusion and in the pathogenesis of IS [ 54 56 ].…”
Section: Discussionmentioning
confidence: 99%
“…Orally administrated at 156 mg/kg, berberine improved endothelial dysfunction by reducing aortic ROS generation and the release of inflammatory cytokines in the serum of a mouse model of atherosclerosis ( Tan et al, 2020 ). Additionally, platelet–endothelial cell interactions potentiated by oxidative stress are thought to contribute to early atherosclerosis ( Brown et al, 2021 ). Existing inflammatory and oxidative suppression of berberine prevented the development of the atherosclerotic plaque area by inhibiting translocation of NF-κB to the nucleus ( Feng et al, 2017 ).…”
Section: Effects Of Berberine On Vascular Diseasesmentioning
confidence: 99%
“…MCE molecular imaging relies on purely intravascular multivalent particles that bear shear-dependent ligands, thereby closely mimicking platelet GP Ibα-dependent ligation. 25 In previous studies, including in nonhuman primate models, 37 and in the current study (Figure S6), circulating markers such as VWF antigen or multimer size fail to accurately reflect proteolysis of endothelialassociated VWF, which is influenced by shear and, in this case, is occurring in a single organ. Instead, validated molecular imaging techniques for examining endothelialassociated VWF A1 domain and platelet adhesion were used.…”
Section: Discussionmentioning
confidence: 50%